Answers are grounded in this paper and cite their sources.
Due to its rarity, there is insufficient evidence for managing ASCC patients with distant metastasis. Thus far, the therapeutic strategy for distant metastasis of ASCC is less standardized and requires a more individualized approach. Therefore, it is crucial to obtain information regarding treatment outcomes and prognostic factors following the development of distant metastasis to identify optimal care strategies for better patient outcomes and predict their prognosis.
No takes yet. Share an insight, caveat, or question.
Matsuyama et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: